BLK
BlackRock, Inc.
BLK offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CNO
CNO Financial Group, Inc.
CNO has the edge over BLK overall, supported by stronger modeled upside and lower modeled downside.
BLK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BLK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BLK.
CNO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
CNO's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CNO.
BLK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $848 | -30% |
| Fair | 22x | $973 | -20% |
| Expensive | 26x | $1,149 | -5.5% |
| Current | 28x | $1,217 | — |
Historical ranges are pointers, not guarantees.
BLK has the edge over CNO in the historical PE scenario, which offers more potential upside but is not a forecast.
CNO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.5x | $28.30 | -51% |
| Fair | 9.1x | $39.72 | -31% |
| Forward | 11x | $57.44 | — |
| Current | 13x | $57.44 | — |
| Expensive | 15x | $66.35 | +16% |
Historical ranges are pointers, not guarantees.
CNO's PE is in its expensive range at 13x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its fair range.
BLK Forward outlook
There aren't enough analyst estimates for BLK to show an outlook.
CNO Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect CNO's earnings to grow and its profitability to improve, with its revenue holding steady.
BLK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $43.87 | +11% |
| Q2 2026 | $41.73 | -0.4% |
| Q1 2026 | $39.73 | -4.7% |
| Q4 2025 | $35.31 | -17% |
| Q3 2025 | $39.42 | -2.7% |
| Q2 2025 | $41.89 | +4% |
| Q1 2025 | $41.69 | +5.9% |
| Q4 2024 | $42.53 | +16% |
BLK has the edge over CNO on earnings, with stronger typical year-over-year growth.
CNO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.03 | +15% |
| Q3 2026 | $4.38 | +53% |
| Q2 2026 | $2.91 | +7.4% |
| Q1 2026 | $2.49 | -13% |
| Q4 2025 | $2.23 | -40% |
| Q3 2025 | $2.86 | +15% |
| Q2 2025 | $2.71 | -30% |
| Q1 2025 | $2.86 | -17% |
| Q4 2024 | $3.74 | +55% |
CNO earned $4.38 per share over the past year, up 53% from the year before.
BLK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.8B | +19% |
| Q2 2026 | $7.1B | +31% |
| Q1 2026 | $6.7B | +27% |
| Q4 2025 | $7B | +23% |
| Q3 2025 | $6.5B | +25% |
| Q2 2025 | $5.4B | +13% |
| Q1 2025 | $5.3B | +12% |
| Q4 2024 | $5.7B | +23% |
BLK has the edge over CNO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | 0 points |
| Q2 2026 | 35% | +2.8 points |
| Q1 2026 | 42% | +9.8 points |
| Q4 2025 | 24% | -13 points |
| Q3 2025 | 30% | -8.6 points |
| Q2 2025 | 32% | -5.5 points |
| Q1 2025 | 32% | -3.6 points |
| Q4 2024 | 37% | +2.3 points |
BLK has the edge over CNO on profitability, with a higher operating margin.
CNO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | -8.6% |
| Q2 2026 | $1.3B | +12% |
| Q1 2026 | $1B | +2.5% |
| Q4 2025 | $1.1B | +4.2% |
| Q3 2025 | $1.2B | +5.2% |
| Q2 2025 | $1.2B | +8% |
| Q1 2025 | $1B | -13% |
| Q4 2024 | $1.1B | -6.3% |
CNO's revenue grew through 2024 and has held roughly level since: $1.1B last quarter, down 8.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +6.6 points |
| Q2 2026 | 12% | +2 points |
| Q1 2026 | 13% | +2.2 points |
| Q4 2025 | 15% | -0.7 points |
| Q3 2025 | 14% | +0.1 points |
| Q2 2025 | 9.8% | -4.2 points |
| Q1 2025 | 10% | +4 points |
| Q4 2024 | 16% | +1.2 points |
CNO's operating margin was 20% last quarter, up 6.6 points from the same quarter a year ago, near the top of its range since 2019.
BLK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +95% |
| Q2 2026 | $1.1B | -12% |
| Q1 2026 | -$1.1B | +$120M |
| Q4 2025 | $2.1B | -15% |
| Q2 2025 | $1.3B | -6.1% |
| Q1 2025 | -$1.2B | -$734M |
| Q4 2024 | $2.5B | +35% |
| Q2 2024 | $1.4B | +47% |
BLK's free cash flow was $4.8B over the past year, up 22% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BLK.
CNO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $242M | +22% |
| Q2 2026 | $156.6M | +7.6% |
| Q1 2026 | $148.8M | +8.9% |
| Q4 2025 | $195.7M | +2.5% |
| Q3 2025 | $197.8M | -14% |
| Q2 2025 | $145.5M | +31% |
| Q1 2025 | $136.7M | +45% |
| Q4 2024 | $191M | +8.1% |
CNO has the edge over BLK on cash flow, with more consistent year-over-year improvement.
BLK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -148K shares |
| 1 year | -0.4% | -677K shares |
| 3 years | +9.3% | +14M shares |
| 5 years | +6.2% | +9.6M shares |
| Available history | +4.4% | +7M shares |
BLK has 165M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | $396M |
| Q1 2025 | $657M |
| Q4 2024 | $386M |
| Q2 2024 | $519M |
| Q1 2024 | $634M |
| Q4 2023 | $384M |
| Q3 2023 | $396M |
| Q2 2023 | $383M |
CNO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -699K shares |
| 1 year | -4.4% | -4.3M shares |
| 3 years | -18% | -20.2M shares |
| 5 years | -27% | -34.8M shares |
| Available history | -40% | -62.9M shares |
CNO has the edge over BLK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $59.5M |
| Q2 2026 | $60.9M |
| Q1 2026 | $73.3M |
| Q4 2025 | $60.2M |
| Q3 2025 | $60.6M |
| Q2 2025 | $100.3M |
| Q1 2025 | $110.3M |
| Q4 2024 | $91.7M |
CNO spent $254M buying back its own shares over the past year, down 30% from the year before.
BLK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.3x | Very low |
| Q4 2023 | 0.1x | Very low |
BLK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BLK.
CNO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -1.2x | Net Cash |
| Q4 2024 | -2.4x | Net Cash |
CNO has the edge over BLK on leverage, with a lower net debt burden relative to earnings.
BLK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 79.0 | Neutral |
BLK's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
CNO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.3 | Neutral |
| Stochastic | 74.8 | Neutral |
CNO's weekly RSI is 63 (neutral) and its Stochastic is 75 (neutral).
BLK PE vs Financial Services Sector
| Metric | BLK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 113% above |
| PE % | 97 | 63 | 34 pts above |
BLK is trading at 28x earnings, a 113% premium to the Financial Services sector's median of 13x.
CNO PE vs Financial Services Sector
| Metric | CNO | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.7% above |
| PE % | 72 | 63 | 9 pts above |
CNO has the edge over BLK on valuation relative to its sector.
BLK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,128.0 | 7.9% above |
| 20 week MA | $1,108.9 | 9.7% above |
| 50 week MA | $1,071.6 | 14% above |
| 100 week MA | $1,051.1 | 16% above |
| 200 week MA | $914.1 | 33% above |
BLK is in an uptrend: it's above all five of its weekly moving averages, and 33% above its 200-week average.
CNO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $55.0 | 4.5% above |
| 20 week MA | $54.6 | 5.2% above |
| 50 week MA | $48.1 | 19% above |
| 100 week MA | $43.5 | 32% above |
| 200 week MA | $35.4 | 62% above |
CNO is in an uptrend: it's above all five of its weekly moving averages, and 62% above its 200-week average.
BLK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $503.0 | $707.2 | +41% |
| 2021 | $707.2 | $913.9 | +29% |
| 2022 | $913.9 | $703.9 | -23% |
| 2023 | $703.9 | $811.8 | +15% |
| 2024 | $811.8 | $1,044.2 | +29% |
| 2025 | $1,044.2 | $1,088.1 | +4.2% |
| 2026 YTD | $1,088.1 | $1,216.6 | +12% |
BLK has finished higher in five of the last six years. It's up 12% so far in 2026.
CNO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.2 | $22.8 | +25% |
| 2021 | $22.8 | $24.0 | +5% |
| 2022 | $24.0 | $22.9 | -4.6% |
| 2023 | $22.9 | $27.9 | +22% |
| 2024 | $27.9 | $37.3 | +34% |
| 2025 | $37.3 | $43.3 | +16% |
| 2026 YTD | $43.3 | $57.4 | +33% |
CNO has the edge over BLK on returns for 2026, with the stronger performance.